RGLS - Regulus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RGLS is currently covered by 3 analysts with an average price target of $15.32. This is a potential upside of $13.85 (942.18%) from yesterday's end of day stock price of $1.47.

Regulus Therapeutics's activity chart (see below) currently has 21 price targets and 35 ratings on display. The stock rating distribution of RGLS is 90.91% BUY and 9.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.44% with an average time for these price targets to be met of 89.5 days.

Highest price target for RGLS is $10, Lowest price target is $3, average price target is $15.32.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 30-Oct-2024. First documented stock forecast 22-Oct-2014.

Best performing analysts who are covering RGLS - Regulus Therapeutics:

Madhu Kumar Liana Moussatos Jim Birchenough Whitney Ijem Raghuram Selvaraju Matthew Luchini

Currently out of the existing stock ratings of RGLS, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$8.53 (580.27%)

$10

11 days ago
(30-Oct-2024)

1/10 (10%)

$8.44 (541.03%)

255

Hold

$3

$1.53 (104.08%)

7 months 28 days ago
(13-Mar-2024)

1/4 (25%)

$0.57 (23.46%)

139

Buy

$12

$10.63 (775.91%)

1 years 1 months 20 days ago
(21-Sep-2023)

0/1 (0%)

$10.71 (830.23%)

Hold

$4.2

$2.73 (185.71%)

$48

2 years 9 months 20 days ago
(21-Jan-2022)

2/3 (66.67%)

$1.96 (87.50%)

63

Hold

$30

$28.53 (1940.82%)

6 years 2 months 27 days ago
(14-Aug-2018)

3/4 (75%)

$-1.56 (-4.94%)

80

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RGLS (Regulus Therapeutics) average time for price targets to be met?

On average it took 89.5 days on average for the stock forecasts to be realized with a an average price target met ratio 29.44

Which analyst has the current highest performing score on RGLS (Regulus Therapeutics) with a proven track record?

MADHU KUMAR

Which analyst has the current lower performing score on RGLS (Regulus Therapeutics) with a proven track record?

MATTHEW LUCHINI

Which analyst has the most public recommendations on RGLS (Regulus Therapeutics)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on RGLS

Which analyst is the currently most bullish on RGLS (Regulus Therapeutics)?

Matthew Luchini with highest potential upside - $162.93

Which analyst is the currently most reserved on RGLS (Regulus Therapeutics)?

Jim Birchenough with lowest potential downside - $1.53

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?